A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Annales Pharmaceutiques Françaises
- Vol. 79 (6) , 640-651
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Development and validation of analytical method for quantitation of Emtricitabine, Tenofovir, Efavirenz based on HPLCArabian Journal of Chemistry, 2018
- Simultaneous HPLC Method Development and Validation for Estimation of Lamivudine, Abacavir and Dolutegravir in Combined Dosage Form with their Stability StudiesAsian Journal of Chemistry, 2016
- Development and validation of stability-indicating HPLC method for simeltaneous determination of Lamivudine, Tenofovir, and Dolutegravir in bulk and their tablet dosage formFuture Journal of Pharmaceutical Sciences, 2015
- Tenofovir: What We Have Learnt After 7.5 Million Person-Years of UseInfectious Diseases and Therapy, 2015
- Development of forced degradation and stability indicating studies of drugs—A reviewJournal of Pharmaceutical Analysis, 2014
- RP-HPLC method for simultaneous estimation of lamivudine, tenofovir disoproxil fumarate and efavirenz in tablet formulationJournal of Analytical Chemistry, 2013
- RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage formPharmaceutical Methods, 2012
- Development and validation of a normal-phase HPTLC method for the simultaneous analysis of Lamivudine and Zidovudine in fixed-dose combination tabletsJournal of Pharmaceutical Analysis, 2012
- Development and validation of an HPLC‐UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteersDrug Testing and Analysis, 2012
- Tenofovir Disoproxil FumarateDrugs, 2005